The digital health firm raised its full-year guidance after reporting 42% revenue growth in Q1 2026.
Omada Health increased its 2026 revenue forecast to $322M-$330M and adjusted EBITDA guidance to $14M-$20M. The update follows a strong Q1 2026, where revenue grew 42% year-over-year.
Management attributed the raise to higher gross margins and positive adjusted EBITDA, outperforming prior expectations. The company had not previously disclosed a specific EBITDA range for 2026.
CEO Sean Duffy called the quarter a milestone, citing improved profitability metrics compared to the same period last year.